March 6, 2021
Patients With Pretreated SCLC Have Improved Outcomes
Patients with pretreated SCLC have improved outcomes. Apatinib combined with chemotherapy in patients with prior treatments indicate good efficacy/safety.
Cancer Network
Research News
Latest Advances in Lung Cancer Research
Explore our curated selection of the latest breakthroughs in lung cancer research.
-
-
March 6, 2021
IASLC Discusses Lung Cancer Care and Research Disparities
IASLC discusses lung cancer care and research disparities among socioeconomic, ethnic, racial, and gender-related groups.
BioSpace
-
February 11, 2021
How Biomarkers Impact Treatment Decisions
How biomarkers impact treatment decisions. Biomarkers indicate that a patient’s immune system knows that the tumor is there.
CURE Magazine
-
February 2, 2021
Racial Disparities in Lung Cancer
A sizable body of research has long shown racial disparities in treatment and survival between Black and White patients with lung cancer.
Pulmonology Advisor
-
January 8, 2021
Trailblazer KRAS treatment filed with FDA
Amgen has filed its trailblazer KRAS inhibiting drug treatment with the FDA for a group of lung cancer patients with an aggressive form of the disease.
PharmaPhorum
Get the latest lung cancer research news directly in your inbox.
Learn more about:
- the latest science in lung cancer
- stories about living with lung cancer
- how LCFA is working to fund more lung cancer research grants
LCFA prioritizes providing reliable information about new diagnostics, treatments, and prevention strategies, including exciting FDA-approved personalized therapies based on individual tumor biomarkers. Human-reviewed, AI-created content is used to create some of the summaries for the articles listed.